Clinical trial
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
NCT05767931
Study timeline
Study start (estimated)2023-03-06Date precision: day
Registry last updated2023-03-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Invasive Breast Cancerunresolved
Interventions
Sponsors & collaborators
Peking Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05767931 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.